Диссертация (1140160), страница 26
Текст из файла (страница 26)
Cancer Res.2006;66:8814–21.188.Qian DZ, Kato Y, Shabbeer S, Wei Y, Verheul HMW, Salumbides B. et al.Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acidderivative LBH589. Clin Cancer Res. 2006;12:634–642.189.Riedel SS, Neff T, Bernt KM // Histone profiles in cancer. // PharmacolTher. 2015 Jul 22.
pii: S0163-7258(15)00142-4.190.Riggs M, Neumann RWJ, Ingram V. n-Butyrate causes histone modification inHeLa and Friend erythroleukaemia cells. Nature.1977;268:462–4.191.Robert T, Vanoli F, Chiolo I, Shubassi G, Bernstein KA, Rothstein R. et al.HDACs link the DNA damage response, processing of double-strand breaks and autophagy.Nature. 2011;471:74–9.196192.Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of humanpapillomavirus and implications for clinical focus on persistent infections.
J Natl Cancer Inst2008; 100:513Y7.193.Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirustesting for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: aran- domised controlled trial. Lancet Oncol 2010;11:249Y57.194.Rössig L, Li H, Fisslthaler B, Urbich C, Fleming I, Förstermann U. et al.Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxidesynthase and compromise endothelial cell function in vasorelaxation and angiogenesis.
CircRes. 2002;91:837–844195.Saenz Robles MT, Shivalila C, Wano J, Sorrells S, Roos A, Pipas JM. Twoindependent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns ofcellular histone acetylation, and immortalize primary cells. J Virol. 2013;87:13499–13509.196.Saleem M, Abbas K, Manan M, Ijaz H, Ahmed B, Ali M, Hanif M, FarooqiAA, Qadir MI. // Review-Epigenetic therapy for cancer // Pak J Pharm Sci.
2015May;28(3):1023-32.197.Sasieni P, Castanon A, Cuzick J. Effectiveness of cer- vical screening with age:population based case-control study of prospectively recorded data. BMJ 2009;339:b2968.198.Sawa H, Murakami H, Ohshima Y, Sugino T, Nakajyo T, Kisanuki T. et al.Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosisthrough an increase of the bcl-2-related protein Bad. Brain Tumor Pathol. 2001;18:109–14.199.Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new toolsand old barriers. Cancer 2010;116:2531Y42. 28.
Castle PE, Stoler MH, Solomon200.Schantz A, Thormann L. Cryosurgery for Dysplasia of the uterine ectocervix.Acta Obstetricia et Gynecologica Scandinavica 1984;63:417–20.201.SchapiraM.Structuralbiologyofhumanmetal-dependenthistonedeacetylases. Handb Exp Pharmacol. 2011;206:225–240.202.Schiffman M, Glass AG, Wentzensen N, et al. A long- term prospective study oftype-specific human papillomavirus infection and risk of cervical neoplasia among 20,000women in the Portland Kaiser Cohort Study. Cancer Epidemiol Bio- markers Prev2011;20:1398Y1409.197203.Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.
Humanpapillomavirus and cervical cancer.// Lancet. 2007 Sep 8;370(9590):890-907.204.Screening for Cervical Cancer: A Decision Analysis for the U.S. PreventiveServices Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2011.AHRQ Publication No.11-05157-EF-1.205.Seeber LM, van Diest PJ.// Epigenetics in ovarian cancer.// Methods MolBiol. 2012;863:253-69.206.Seton-Rogers S.// Epigenetics: Chromatin reorganization on a 'mega' scale.// NatRev Cancer. 2015 Aug 13. doi: 10.1038/nrc4004.207.Sherman ME, Lorincz AT, Scott DR, et al.
Baseline cytology, humanpapillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl CancerInst 2003; 95:46Y52.208.Shin HJ, Baek KH, Jeon AH, Kim SJ, Jang KL, Sung YC. et al. Inhibition ofhistone deacetylase activity increases chromosomal instability by the aberrant regulation ofmitotic checkpoint activation.Oncogene. 2003;22:3853–8.209.Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD//Quantitative DNA methylation analysis of candidate genes in cervical cancer.// PLoSOne. 2015 Mar 31;10(3):e0122495.210.Siegel R, Naishadham D, Jemal A.
Cancer statistics, 2012. CA Cancer J Clin2012;62:10Y29.211.Song C, Zhu S, Wu C, Kang J.// Histone deacetylase (HDAC) 10 suppressescervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9expression.// J Biol Chem.
2013 Sep 27;288(39):28021-33. doi: 10.1074/jbc.M113.498758.Epub 2013 Jul 29.212.Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancerafter treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:2048Y55.213.Soutter WP, deBarrosLopesA, FletcherA, MonaghanJM, DuncanID, Paraskevaidis E, Kitchener HC. // Invasive cervical cancer after conservative therapyfor cervical intraepithelial neoplasia // Lancet. 1997 Apr 5;349(9057):978-80.214.Spence AR, Goggin P, Franco EL.
Process of care failures in invasive cervicalcancer: systematic review and meta-analysis. Prev Med 2007;45:93Y106.198215.Stoler MH, Schiffman M. Interobserver reproduci- bility of cervical cytologicand histologic interpretations: real- istic estimates from the ASCUS-LSIL Triage Study. JAMA2001; 285:1500Y5.216.Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Trade-offs in cervicalcancer prevention: balancing benefits and risks. Arch Intern Med 2008;168:1881Y9.217.Strahl BD, Allis CD.
The language of covalent histone modifications.Nature.2000;403:41–45218.Sui X, Zhu J, Zhou J, Wang X, Li D, Han W, Fang Y, Pan H.// Epigeneticmodifications as regulatory elements of autophagy in cancer.// Cancer Lett. 2015 May1;360(2):106-13. doi: 10.1016/j.canlet.2015.02.009. Epub 2015 Feb 14.219.Takai N, Koeffler HP, Narahara H (2007a). Histone deacetylase inhibitors inducegrowth inhibition, cell cycle arrest and apoptosis in human cervical cancer cells.
In ‘NewResearch on Cervical Cancer’, Eds Rolland GZ. Nova Science Publishers Inc., Hauppauge,NY, USA. pp 175–88.220.Takai N, Narahara H (2007b). Human endometrial and ovarian cancer cells:histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cyclearrest, and stimulate apoptosis. Curr Med Chem, 14, 2548–53.221.Takai N, Narahara H (2010a).
Histone deacetylase inhibitor therapy in epithelialovarian cancer. J Oncol222.Takai N, Narahara H (2010b). Preclinical studies of chemotherapy using histonedeacetylase inhibitors in endometrial cancer. Obstet Gynecol Int,223.Talbert PB, Ahmad K, Almouzni G, Ausio J, Berger F, Bhalla PL, Bonner WM,Cande WZ, Chadwick BP, Chan SW, Cross GA, Cui L, Dimitrov SI, Doenecke D, Eirin-LopezJM, Gorovsky MA, Hake SB, Hamkalo BA, Holec S, Jacobsen SE, Kamieniarz K, KhochbinS, Ladurner AG, Landsman D, Latham JA, Loppin B, Malik HS, Marzluff WF, Pehrson JR,Postberg J, Schneider R, Singh MB, Smith MM, Thompson E, Torres-Padilla ME, TremethickDJ, Turner BM, Waterborg JH, Wollmann H, Yelagandula R, Zhu B, Henikoff S.
A unifiedphylogeny-based nomenclature for histone variants. Epigenetics Chromatin. 2012;5:7.224.Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Novel histone deacetylase inhibitors inclinical trials as anti-cancer agents. J Hematol Oncol.2010;3:1–13.199225.Trietsch MD, Nooij LS, Gaarenstroom KN, van Poelgeest MI // Genetic andepigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review ofthe current literature. //Gynecol Oncol. 2015 Jan;136(1):143-57.226.Tsuji N, Kobayashi M, Nagashima K (1976).
A new antifungal antibiotic,trichostatin. J Antibiot, 29, 1-6.227.Ulrich D, Tamussino K, Petru E, Haas J, Reich O.// Conization of the uterinecervix: does the level of gynecologist's training predict margin status? // Int J GynecolPathol. 2012 Jul;31(4):382-6228.Vahid F, Zand H, Nosrat-Mirshekarlou E, Najafi R, Hekmatdoost A// The roledietary of bioactive compounds on the regulation of histone acetylases and deacetylases:a review.// Gene.
2015 May 10;562(1):8-15. doi: 10.1016/j.gene.2015.02.045. Epub 2015 Feb19.229.Völkel P, Dupret B, Le Bourhis X, Angrand PO // Diverse involvement of EZH2in cancer epigenetics.// Am J Transl Res. 2015 Feb 15;7(2):175-93.230.Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is anecessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12Y9.231.Weichert W. HDAC expression and clinical prognosis in human malignancies.Cancer Lett. 2009;280:168–176.232.WHO Classification of Tumours of Female Reproductive Organs is the sixthvolume in the Fourth Edition of the WHO series on histological and genetic typing of humantumors (4th Ed, Vol 6) // Edited by Robert J. Kurman, Maria-Luisa Carcangiu, C.
SimonHerrington, Robert H. Young 2014 (4th ed), 316 pages,233.WHO guidelines for screening and treatment of precancerous lesions for cervicalcancer prevention. World Health Organization 2013. ISBN 978 92 4 154869 4, WHO 2013 г.)234.Wilson GA, Lechner M, Koferle A, Caren H, Butcher LM, Feber A, Fenton T,Jay A, Boshoff C, Beck S. Integrated virus-host methylome analysis in head and necksquamous cell carcinoma. Epigenetics.2013;8:953–961.235.Wollebo HS, Woldemichaele B, Khalili K, Safak M, White MK. Epigeneticregulation of polyomavirus JC. Virol J. 2013;10236.Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use ofhuman papillomavirus DNA testing as an adjunct to cervical cytology for screening. ObstetGynecol 2004;103:304Y9.200237.Wright TC Jr, Schiffman M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
